Beginning Cash: The amount of cash reported by the company on its previous statement.
Mainz Biomed NV (MYNZ) had Beginning Cash of $17.14M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$0.90M |
|
$-26.30M |
|
$0.39M |
|
$0.51M |
|
$27.54M |
|
$-26.64M |
|
$0.35M |
|
$-26.30M |
|
$-26.30M |
|
$-26.30M |
|
$-26.30M |
|
$-26.30M |
|
$-26.30M |
|
$-26.64M |
|
$-25.78M |
|
16.24M |
|
16.24M |
|
$-1.62 |
|
$-1.62 |
|
| Balance Sheet Financials | |
$8.98M |
|
$1.70M |
|
$6.43M |
|
$15.41M |
|
$9.24M |
|
$1.17M |
|
$2.92M |
|
$12.16M |
|
$3.25M |
|
$-0.15M |
|
$3.25M |
|
21.16M |
|
| Cash Flow Statement Financials | |
$-21.94M |
|
$-1.90M |
|
$14.23M |
|
|
Beginning Cash |
$17.14M |
$7.07M |
|
$-10.07M |
|
$4.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.97 |
|
-- |
|
-- |
|
0.26 |
|
1.97 |
|
56.91% |
|
-2975.47% |
|
-2975.47% |
|
-2878.71% |
|
-2936.50% |
|
-2936.50% |
|
$-23.14M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
0.63 |
|
9.57 |
|
38.13 |
|
-809.29% |
|
18082.69% |
|
-170.65% |
|
-595.61% |
|
$0.15 |
|
$-1.42 |
|
$-1.35 |
|